TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.

Irene StrasslArmin WindhagerSigrid Machherndl-SpandlVeronika Buxhofer-AuschOlga StiefelAnsgar Weltermann

Published in: Journal of cancer research and clinical oncology (2023)

TOP-PIC provides a detailed, disease-based benefit-risk assessment with recommendations specific for cancer patients with limited life expectancy. Based on the results of the pilot study, the tool seems practicable for day-to-day clinical decision-making and provides evidence-based facts to optimize pharmacotherapy.

Keyphrases

papillary thyroid
risk assessment
decision making
squamous cell
smoking cessation
emergency department
lymph node metastasis
squamous cell carcinoma
climate change
adverse drug